Treatment with NeoCast, a Next-Generation Liquid Embolic, Results in Substantial Chronic Subdural Hematoma Resolution and Functional Outcome Gains in Final EMBO-02 First-in-Human Results
Late-Breaking Data Presented at the Society of Neurointerventional Surgery (SNIS) Annual Meeting WALTHAM, Mass., July 22, 2026 /PRNewswire/ -- Arsenal Medical, a clinical-stage company developing innovative biomaterial-based devices, announced late-breaking results from the EMBO-02...
Late-Breaking Data Presented at the Society of Neurointerventional Surgery (SNIS) Annual Meeting WALTHAM, Mass., July 22, 2026 /PRNewswire/ -- Arsenal Medical, a clinical-stage company developing innovative biomaterial-based devices, announced late-breaking results from the EMBO-02...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.